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Expressions of tnfsf6 and cyp1a1 and screening related genes by GeneChip on
peripheral blood mononuclear cells in patients with Acute Myocardial Infarction
Zhan Hong, Xiong Yan, Cai Ruibing, Ye Zi, Xu Jia, Jiang Peng, Chen Yuemei,
Zhou Yijun Karamath, Ma Zhongfu
Department of Emergency, the ﬁrst hospital of Sun Yan-sen University Guangzhou
510080 China
Objectives: Understand the changes in the genes of oxidative stress and the process
of cell toxic with myocardial IRI due to before and after operative of PCI in
STEMI patients. Observe in a dynamic environment the changes in the mRNA
expression of TNFSF6 and CYP1A1 resulting from myocardial IRI and clinical
signiﬁcance.
Methods: Patients admitted to our ER and CCU from November 2011to February
2012. Consisting of 22 patients, 14 males and 8 females, mean age 63.5212.40 years
with a range from 37 to 91years. All cases are diagnosed based on the AMI diagnosis
criteria under Chinese Medical Association in 2003, For patients with normal controls
with age, sex matching healthy volunteers 12 people, 8 male and 4 female, the average
age 57.006.57 (35-68). Acute onset in STEMI group hospital diagnosed after
extracting cubits 10ml were immediately into containing 0.05 ml of heparin without
bacteria. After acute onset of emergency PCI and conventional treatment, the third day
and the seventh day each pump once again were cubits 10ml; The comparison group:
morning, fasting extraction method 10ml were cubits under the same approach as that
for the patients group. PBMCs separation adopts the lymphocyte separate liquid
density gradient centrifugation. Using Human Stress & Toxicity Pathway Finder PCR
Array screening method of myocardial IRI related gene changes. The validation of
expression of CYP1A1 TNFSF6 by Real time PCR. All data to differences with
meanstandard deviation (xs), Value of patients and controls were compared by
ANOVA analysis. And correlation analysis method, the related to P<0.05 to was
statistically signiﬁcant differences.
Results: (1) Of the STEMI group, general average STEMI genes that signiﬁcant
changes in 14, which were up regulated the gene expression of signiﬁcant for 8, were
signiﬁcant down regulated for four genes.The genes expression were up regulated
which are cell growth/aging related genes1 (GADD45A), oxidation stress and meta-
bolic related gene 1 (PRDX2), Heat shock related gene 3 (HSPD1, DNAJB1,
DNAJB2), and repair DNA damage related gene 1 (RAD50), and apoptosis signal
related gene 2 (TNFSF6 TRADD, ) Signiﬁcant down regulated of those genes: the cell
proliferation/cancer related gene 1 (CCNG1), oxidation or metabolic stress related
gene gene 2 (CAT, CYP1A1), DNA damage and restoration related gene 1 (ATM). (2)
The expression of TNFSF6 in STEMI group is higher than of the healthy group and
CYP1A1 was lower than the normal value.
Conclusions: (1) The moderation of multiple genes resulting from myocardial IRI due
to After PCI with Acute myocardial infarction. It provides a more complete view in
the complication and complexity of myocardial IRI gene regulation. (2) The quanti-
tative analysis of TNFSF 6 and CYP1A1 genes after myocardial IRI in AMI at various
stage. They may be involved in the myocardial ischemia/ reperfusion injury physio-
pathological process.
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Analysis of Bacteroides and Biﬁdobacterium diversity in fecal samples from
patients with coronary artery disease by using PCR-denaturing gradient gel
electrophoresis ﬁngerprint
Zhang Yan, Wu Xiaokang, Li Yongqin
Second Afﬁliated Hospital of Medical School, Xi’an Jiaotong University
Objectives: The investigation provides molecular analyses of the faecal microbiota in
coronary artery disease (CAD). This study aimed to clarify the relationship between
CAD and gut predominant microbiota by analyzing the diversity of Bacteroides and
Biﬁdobacterium.
Methods: In order to assess whether there are changes in the diversity and similarity
of gut microbiota in CAD patients when compared with healthy individuals, bacterial
DNAs from 30 CAD and 30 healthy individuals were extracted from faecal samples
and characterised by PCR-denaturing gradient gel electrophoresis (DGGE) with
primers speciﬁcally targeting V3 region of the 16S rRNA gene. After DGGE
proﬁlings was obtained, the diversity and similarity analyses were carried out by the
number of band, Shannon-Weaver (Hp), cluster analysis and the cumulative distri-
bution curve of similarity.
Results: The range of Shannon-Weaver (Hp) in diabetes group and healthy group was
0. 88 (0.74-0.94) and 0. 94 (0.88-0.96) for Bacteroides; 0.84 (0.74-0.93) and 0. 87
(0.73-0.93) for Biﬁdobacterium. The cumulative distribution curve of intra-group
similarity showed that the Dice similarity coefﬁcient (Cs) lower than (or equal to)
0.5 took up 85. 83% of the total Cs for Bacteroides in diabetes group and 35.71% in
healthy group; the Cs lower than (or equal to) 0.4 constituted 90% of the total Cs forJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CBiﬁdobacterium in CAD group and 60.7% in healthy group. It is showed that the
composition of gut microbiota in CAD group might be changed due to atherosclerosis
status.
Conclusions: Sequencing results also revealed that bacterial composition of CAD
group was different from that of the healthy group. DGGE proﬁling has shown
individual speciﬁcity in CAD group and healthy group for Bacteroides and Biﬁdo-
bacterium. The intra-group similarity of Bacteroides and Biﬁdobacterium is lower in
CAD group than in healthy group. Taken together, in this work we observed the
characterisation of gut microbiota in CAD patients, which suggestes that the gut
microbiota of CAD patients have some changes associated with occurrence and
development of CAD.
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Predictive value of serum uric acid level for left atrial thrombus or spontaneous
echo contrast in patients with atrial ﬁbrillation
Liu Fangzhou, Wei Wei, Xue Yumei, Zhan Xianzhang, Fang Xianhong, Liao Hongtao,
Fei Hongwen, Liu Yang, Wu Shulin
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong
General Hospital, Guangdong Academy of Medical Sciences
Objectives: To investigate the predictive value of serum uric acid (SUA) levels for
left atrial thrombus (LATH)/spontaneous echo contrast (SEC) in patients with atrial
ﬁbrillation (AF).
Methods: The study enrolled 525 patients (Male 337, Female 188, mean age of
60.811.2 years old, 83% paroxysmal AF) with AF who underwent transesophageal
echocardiography (TEE) in Guangdong province cardiovascular institute from July
2007 to January 2013. Patients were categorized into LATH/SEC group (n¼57) and
non-LATH/SEC group (n¼468), according to the TEE results. The clinical baseline of
both groups including age, gender, AF types, SUA levels, indices of echocardiography
and complications were collected and analyzed. The relationships between the
potential risk factors and LATH/SEC were performance using Logistic regression
analysis.
Results: SUA level (391.6398.45umol/L vs 349.2783.93 umol/L, P<0.01), left
atrial diameter (LAD) (41.956.06mm vs 37.445.17mm, P<0.01), proportion of
patients with persistent AF (50.9% vs 13.7%, P<0.01) were signiﬁcantly increased in
patients of LATH/SEC group compared with patients of non-LATH/SEC group. ROC
curve were presented by SUA level, which indicated area under curve was 0.612
(P¼0.006) and the best SUA cut-point was 448.5umol/L. Logistic regression analysis
indicated that female (OR¼2.344, 95% CI 1.228-4.475, P¼0.01), persistent AF
(OR¼5.993, 95% CI 3.127-11.486, P<0.001), SUA level (OR¼2.890, 95% CI 1.380-
6.051, P¼0.005), LAD>40mm (OR¼4.845, 95% CI 2.528-9.284, P<0.001),
CHA2DS2-VASc score (OR¼1.422, 95% CI 1.105-1.829, P¼0.006) were indepen-
dent risk factors of LATH/SEC in patients with AF.
Conclusions: SUA level is independent risk factor and predictive index for LATH/
SEC in patients with AF.
GW25-e3529
Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after
acute myocardial infarction in mice
Tao Lichan1, Li Xinli1, Xiao Junjie1,2
1Department of Cardiology, The First Afﬁliated Hospital of Nanjing Medical
University, 2Regeneration Lab and Experimental Center of Life Sciences, School of
Life Science, Shanghai University
Objectives: Qiliqiangxin (QL), a traditional Chinese medicine, has been approved by
China Food and Drug Administration for the treatment of chronic heart failure since
2004. Recently, a multicenter randomized double-blind study from our group has
proved that QL reduced the levels of B-type natriuretic peptide (BNP) and N-terminal
pro-B-type natriuretic peptide (NT-proBNP) during 12 weeks of treatment in 512
chronic heart failure patients, suggesting that QL may have a protective effect on
injury heart. However, whether QL can improve cardiac remodeling and the underling
mechanism are still unclear.
Methods: Four groups of C57BL/6 adult male mice (saline plus sham, saline plus
AMI remodeling, QL (0.5g/kg/d) plus sham, and QL (0.5g/kg/d) plus AMI remod-
eling) were randomly divided in this study. Echocardiography and histopathology
were detected to evalute cardiac function and morphological changes. TTC staining
and immunoﬂuorescence were used to test myocardial necrosis and apoptosis.
Quantitative reverse transcription polymerase chain reactions (RT-PCRs) and western
blotting were also used to determine the expression levels of peroxisome proliferator-
activated receptor-a (PPAR-a), -b, - g.
Results: QL signiﬁcantly prevented AMI-induced decreases in ejection fraction (%
EF: MI with saline 38%, MI with QL 48%) and fractional shortening (%FS: MI with
saline 18%, MI with QL 22%) after AMI. In addition, QL decreased myocardial
infarct size by 49% and myocardial apoptosis by 40%. Most imoprtantly, PPARg, a
key regulator for cardiac energy metabolism after myocardial injury, was found to
be down-regulated in AMI remodeling and was up-regulated after QL administra-
tion. A selective PPARg activator Rosiglitazone (at a dose of 1mg/kg/d for 21 days
via intraperitoneal injection) itself had a protective effect on cardiac function after
AMI remodeling. Compared with the administration of QL alone, combination of
PPARg activator with QL did not have signiﬁcant difference on cardiac functionardiovascular-Disciplinary Research C235
after AMI remodeling. Importantly, a selective PPARg inhibitor T0070907 (at a
dose of 1 mg/kg/g for 21 days) prevented the protective effects of QL against AMI
remodeling. Cardiac function were decreased after the combination of PPARg in-
hibitor with QL. Myocardial infarct size and apoptosis-related factors were all
increased, conﬁming the inhibition effect of PPARg inhibitor on QL. Thses results
indicated that QL attenuates cardiac remodeling after AMI through PPARg. To
further claify whether QL takes effetcs in acute stage or remodeling stage, mice was
either treated for 3 days or from 3 days-21days. It is found that QL performed
functional effect mainly during chronic stage, and had no evident effect on acute
stage as determined by measuring the percentage of myocardial ischemic infarct
size/area-at-risk (AAR).
Conclusions: QL attenuates cardiac remodeling after AMI. The effects of QL in
attenuating cardiac remodeling after AMI was at least partially via targeting PPARg.
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The remodeling of gallbladder artery and altered expression of calcium handling
genes in hypertensive patients
Shang Qianhui
Institute of Clinical Medicine and Hypertension Research Lab, Department of
Cardiology of Afﬁliated Hospital, Zunyi Medical College
Objectives: The remodeling of gallbladder artery in hypertensive patients and its
underlying mechanisms are poorly understood. The present study observed the
morphological and histological changes of gallbladder arteries and investigated the
mechanisms of calcium handling genes involved in remodeling.
Methods: A total of 44 patients with biliary calculus underwent cholecystectomy at
department of hepatobiliary surgery in Afﬁliated Hospital of Zunyi Medical College
from Jun, 2011 to Mar, 2012. Among them, 21 patients without risk factors were
selected on age and sex-matched method and divided into control group (n¼11,
normal blood pressure) and hypertensive group (n¼10). HE staining and Masson
staining were used to observe the morphology changes of arteries. The intima-media
thickness (IMT), intimal cross-sectional area (ICSA), medial cross-sectional area
(MCSA), collagen volume fraction (CVF) of intima and media was analyzed by
computer image analysis system. The protein expressions of a-smooth muscle actin
(a-SMA) and proliferating cell nuclear antigen (PCNA) were detected by immuno-
histochemical technique. The mRNA expression levels of embryonic smooth
muscle myosin heavy chain (SMemb) and calcium handling genes were detected by
Realtime PCR.
Results: Compared with control group, IMT (79.54.7 vs 51.24.3 mm), intima-
media thickness to internal diameter ratio (IMT/ID) (0.250.02 vs 0.170.01), ICSA
to internal diameter ratio (ICSA/ID) (67.79.2 vs 39.68.7) and MCSA to ID ratio
(MCSA/ID) (242.420.7 vs 153.319.7) were increased in hypertensive group (all
P<0.05); Compared with control group, in intima or media of artery, CVF
(0.360.03 vs 0.170.03; 0.360.02 vs 0.28 0.02, all P<0.05) and cell prolifer-
ation index (0.610.05 vs 0.360.05; 0.730.05 vs 0.540.05, all P<0.01) were
increased in hypertension subjects; In media of artery, the gene expression of SMemb,
sodium pump a1 subunit and transient receptor potential canonical channel type 1
(TRPC1), TRPC3 were increased, while sodium pump a3 subunit and plasma mem-
brane calcium-transporting ATPase 4 were decreased in hypertensive group (all
P<0.05).
Conclusions: This study provides evidences that hypertension is associated with the
remodeling of the gallbladder artery. The phenotypic change of vascular smooth
muscle cell and the abnormal expression of the calcium handling genes may play an
important role in the arterial remodeling.
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The role of neutrophil-lymphocyte ratio in Takayasu arteritis disease monitoring
Liu Qing, Lv Naqiang, Chen Bingwei, Wang Xu, Dang Aimin
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy
of Medical Sciences and Peking Union Medical College
Objectives: Blood neutrophil-lymphocyte ratio (NLR) is an indicator of the overall
inﬂammatory status of the body. Takayasu arteritis (TA) is a chronic non-speciﬁc
inﬂammatory disease. The objective of the present study was to assess whether the
NLR would be useful in TA disease monitoring. Additionally, a possible relationship
between NLR and other inﬂammatory markers in patients with TA was also
investigated.
Methods: Eighty-seven patients and 59 healthy controls were enrolled in the
study. The neutrophil and lymphocyte counts were recorded, and the NLR was
calculated from these parameters. Disease activity and severity in patients with TA
were deﬁned according to the National Institutes of Health and Ishikawa’s criteria,
respectively.
Results: NLR values were higher in patients with TA compared with healthy controls
[2.02 (1.68-3.00) vs. 1.70 (1.37-2.16), P<0.001]. There were also signiﬁcant differ-
ences in the NLR values between patients with active disease and patients in remission
[2.63 (1.95-4.13) vs. 1.81 (1.50-2.38), P<0.001]. Patients with severe TA showed
signiﬁcantly higher NLR values than those with mild-moderate TA [2.09 (1.74-4.20)
vs. 1.94 (1.64-2.68), P¼0.033]. In patients with available longitudinal data, NLR
values at the active phase were signiﬁcantly higher than those at the stable phase [2.86
(2.28-4.84) vs. 2.13 (1.51-3.14), P¼0.001]. Moreover, NLR values were found to be
correlated with inﬂammatory markers, including C-reactive protein (r¼ 0.262,C236 JACC Vol 64/16/Suppl C j October 1P¼0.014), erythrocyte sedimentation rate (r ¼ 0.255, P¼0.017), and white blood cell
count (r ¼ 0.429, P<0.001).
Conclusions: NLR values were signiﬁcantly increased in patients with active TA
exhibiting severe complications. These results indicated that NLR may be a useful
marker to assess disease activity, severity, and progression of TA.
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Pharmacologic approach to defective protein trafﬁcking in the E637K-hERG
mutant with PD-118057 and thapsigargin
Mao Haiyan1,2,3, Lian Jiangfang1,4
1LiHuiLi Hospital, 2People’s Hospital of Anji County, 3Department of Thoracic
Surgery, Memorial Sloan-Kettering Cancer Center, 4Department of Pathology, Key
Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University
Objectives: Treatment of LQT2 is inadequate. Many drugs which can pharmaco-
logically rescue defective protein trafﬁcking in LQT2 also result in potent blockade of
HERG current, negating their therapeutic beneﬁt. It is reported that PD-118057 and
thapsigargin can rescue LQT2 without hERG channel blockade, but the precise
mechanism of action is unknown. Furthermore, the effect of PD-118057 and thapsi-
gargin on the dominant negative E637K-hERG mutant has not been previously
investigated.
Methods: The whole-cell Patch-clamp technique was used to assess the effect of PD-
118057 and thapsigargin on the electrophysiological characteristics of the rapidly
activating delayed rectiﬁer K+ current (Ikr) of the hERG protein channel.Western blot
was done to investigate pharmacological rescue on hERG protein channel function.
Results: In our study, PD-118057 was shown to signiﬁcantly enhance both the
maximum current amplitude and tail current amplitude, but did not alter the gating and
kinetic properties of the WT-hERG channel, with the exception of accelerating steady-
state inactivation. Additionally, thapsigargin shows a similar result as PD-118057 for
the WT-hERG channel, but with the exception of attenuating steady-state inactivation.
However, for the WT/E637K-hERG channel, PD-118057 had no effect on either the
current or on the gating and kinetic properties. Furthermore, thapsigargin treatment did
not alter the current or the gating and kinetic properties of the WT/E637K-hERG
channel, with the exception of opening at more positive voltages.
Conclusions: Our ﬁndings illustrate that neither PD-118057 nor thapsigargin play a
role in correcting the dominant-negative effect of the E637K-hERG mutant.
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Frequency of Hyponatremia and Short Term Clinical Outcomes in Patients
Hospitalized for Heart Failure
Farooq Ahmad, Mohammad Haﬁzullah
Emergency Satellite Hospital KPK, Room No. A21, TMO Hostel Lady Reading
Hospital Peshawar Pakistan
Objectives: The objective of this study was to determine the frequency of hypona-
tremia and short term clinical outcomes in patients hospitalized for heart failure.
Methods: This study was carried out from August 9, 2011, to July 29, 2012. Both
male and female patients aged 14 years and above admitted for heart failure fulﬁlling
the inclusion criteria, were included in the study. Admission Serum sodium was
measured in all patients. Those having serum sodium of 135mmol/L were deﬁned as
hyponatremic. All the patients were managed according to guidelines. All patients
were followed during their hospital stay. Patients who survived were discharged on
standard HF medications and followed till the end of six month for 6-month mortality
and re-admissions for heart failure.
Results: A total of 241 patients were included in the study. Mean age was 59.214.9
(18-100) years. The number of female patients was 123 (51%) while male were 118
(49%). Based on age patients were divided into two groups, Group I included patients
less than 60 years (41.9%, n-101)and Group II included 60 years and above (58.1%
(n-140). Mean serum sodium was 1365.1mmol/L (116-151). Hyponatremia (serum
sodium 135mmol/L) was found in 35.3% (85) patients. The overall in-hospital
mortality rate was 5.4%. Lower admission serum sodium was associated with higher
in-hospital mortality, 8.2% for the lower sodium group compared with 3.8% for those
patients with normal serum sodium (P¼0.23). Mean length of hospital stay (LOS) for
overall CHF patients was 3.82.4 days. Lower admission serum sodium was asso-
ciated with longer mean hospital LOS, 4.12.3 for lower sodium group compared
with 3.72.4 for normonatremic group. Overall 6-month follow up mortality was
19.6%, while it was higher in hyponatremic group 28.0% compared to normonatremic
patients 15.3% (P¼0.03). Six month follow up readmission rate was 30.7%. Hypo-
natremic group had readmission rate of 34.7% compared with 28.7% in normona-
tremic patients (P¼0.36).
Conclusions: Hyponatremia in hospitalized patients with heart failure is common and
is associated with longer hospital stay, higher in-hospital and early post-discharge
mortality.
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Effects of CD147/MMP-2 Pathway on Early Left Ventricular Remodeling in
Spontaneously Hypertensive Rats
Li Bowei, Zhou Wanxing
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